Advanced search
Publication Cover
Expert Review of Hematology Volume 14, 2021 - Issue 12: Multiple Myeloma
Submit an article Journal homepage
7,605
Views
3
CrossRef citations to date
0
Altmetric
Review

Chromosomal 1q21 abnormalities in multiple myeloma: a review of translational, clinical research, and therapeutic strategies

Kamlesh Bishta Oncology Therapeutic Area, Sanofi Research and Development, Cambridge, MA, USACorrespondence[email protected]
View further author information
,
Brian Walkerb Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology Oncology, Indiana University, Indianapolis, IN, USAView further author information
,
Shaji K. Kumarc Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USAView further author information
,
Ivan Spickad First Department of Medicine, Department of Hematology, First Faculty of Medicine, Charles University and General Hospital, Prague, Czech RepublicView further author information
,
Philippe Moreaue Department of Hematology, University Hospital of Nantes, Nantes, FranceView further author information
,
Tom Martinf Department of Medicine, University of California, San Francisco, CA, USAView further author information
,
Luciano J. Costag Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, USAView further author information
,
Joshua Richterh Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY, USAView further author information
,
Taro Fukaoa Oncology Therapeutic Area, Sanofi Research and Development, Cambridge, MA, USAView further author information
,
Sandrine Macéi Sanofi Research and Development, Sanofi, Vitry-Sur-Seine, FranceView further author information
&
Helgi van de Veldea Oncology Therapeutic Area, Sanofi Research and Development, Cambridge, MA, USAView further author information
 show all
Pages 1099-1114 | Received 30 Jul 2021, Accepted 17 Sep 2021, Published online: 08 Oct 2021

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Pan Zhou, Weiya Li, Suqiong Zuo, Rongjun Ma, Xiaoli Yuan & Zunmin Zhu. (2023) Pathogenesis, clinical characteristics and personalized managements of multiple myeloma with chromosome 1 abnormalities. Leukemia & Lymphoma 64:8, pages 1373-1388.
Read now

Articles from other publishers (2)

Emiliano Barbieri, Monica Maccaferri, Giovanna Leonardi, Francesca Giacobbi, Giorgia Corradini, Ivana Lagreca, Patrizia Barozzi, Leonardo Potenza, Roberto Marasca & Mario Luppi. (2022) Adverse outcome associated with daratumumab-based treatments in relapsed/refractory multiple myeloma patients with amplification of chromosome arm 1q21: a single-center retrospective experience. Annals of Hematology 101:12, pages 2777-2779.
Crossref
Tom Martin, Paul G Richardson, Thierry Facon, Philippe Moreau, Aurore Perrot, Ivan Spicka, Kamlesh Bisht, Marlene Inchauspé, France Casca, Sandrine Macé, Helgi Van de Velde & Kenshi Suzuki. (2022) Primary outcomes by 1q21+ status for isatuximab-treated patients with relapsed/refractory multiple myeloma: subgroup analyses from ICARIA-MM and IKEMA. Haematologica 107:10, pages 2485-2491.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.